Regulation of angiogenesis by a small GTPase Rap1

Vascular Pharmacology

Volumn 53, Issue 1-2, 2010, Pages 1-10

  Chrzanowska Wodnicka, Magdalena ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Blood vessel formation; Endothelial barrier; Endothelium; FGF; VEGF

Indexed keywords

BONE MARROW PROTEIN TYROSINE KINASE IN CHOMOSOME X; CELL ADHESION MOLECULE; FIBROBLAST GROWTH FACTOR 2 RECEPTOR; GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE; INTEGRIN; ISOPROTEIN; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE C; PROTEIN TYROSINE KINASE; RAP1 PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL JUNCTION; CELL MIGRATION; CYTOSKELETON; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; EYE DEVELOPMENT; HUMAN; IN VITRO STUDY; NONHUMAN; OPTIC NERVE; PERMEABILITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RAP1 GTP-BINDING PROTEINS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952549816     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.03.003     Document Type: Review

References (132)

1. Abassi Y.A., Rehn M., Ekman N., Alitalo K., and Vuori K. p130(Cas) couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. J. Biol. Chem. 278 (2003) 35636-35643
2. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., Valladares A., Perez L., Klein R., and Nebreda A.R. Essential role of p38[alpha] MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6 (2000) 109-116
3. Adamson R.H., Ly J.C., Sarai R.K., Lenz J.F., Altangerel A., Drenckhahn D., and Curry F.E. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H1188-1196
4. Arthur W.T., Quilliam L.A., and Cooper J.A. Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J. Cell Biol. 167 (2004) 111-122
5. Asuri S., Yan J.L., Paranavitana N.C., and Quilliam L.A. E-cadherin Dis-engagement activates the Rap1 GTPase. J. Cell. Biochem. 105 (2008) 1027-1037
6. Avraamides C.J., Garmy-Susini B., and Varner J.A. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer. 8 (2008) 604-617
7. Balzac F., Avolio M., Degani S., Kaverina I., Torti M., Silengo L., Small J.V., and Retta S.F. E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function. J. Cell Sci. 118 (2005) 4765-4783
8. Bertoni A., Tadokoro S., Eto K., Pampori N., Parise L.V., White G.C., and Shattil S.J. Relationships between Rap1b, affinity modulation of integrin alpha IIbbeta 3, and the actin cytoskeleton. J. Biol. Chem. 277 (2002) 25715-25721
9. Boettner B., and Van Aelst L. Control of cell adhesion dynamics by Rap1 signaling. Curr. Opin. Cell Biol. 21 (2009) 684-693
10. Bokoch G. Biology of the Rap proteins, members of the ras superfamily of GTP-binding proteins. Biochem. J. 289 (1993) 17-24
11. Borland G., Smith B.O., and Yarwood S.J. EPAC proteins transduce diverse cellular actions of cAMP. Br. J. Pharm. 9999 (2009)
12. Bos J.L. Linking Rap to cell adhesion. Curr. Opin. Cell Biol. 17 (2005) 123-128
13. Bos J.L., de Rooij J., and Reedquist K. Rap1 signalling: adhering to new models. Nat. Rev. Mol. Cell Biol. 2 (2001) 369-77
14. Bos J.L., Rehmann H., and Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 129 (2007) 865-877
15. Brooks P.C., Clark R.A., and Cheresh D.A. Requirement of vascular integrin [alpha]v[beta]3 for angiogenesis. Science 264 (1994) 569-571
16. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
17. Carmeliet P., Lampugnani M.-G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oosthuyse B., and Dewerchin M. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (1999) 147-157
18. Carmona G., Gottig S., Orlandi A., Scheele J., Bauerle T., Jugold M., Kiessling F., Henschler R., Zeiher A.M., Dimmeler S., and Chavakis E. Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood 113 (2009) 488-497
19. Caron E. Cellular functions of the Rap1 GTP-binding protein: a pattern emerges. J. Cell Sci. 116 (2003) 435-440
20. Cary L.A., Chang J.F., and Guan J.L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 109 (1996) 1787-1794
21. Chrzanowska-Wodnicka M., Smyth S.S., Schoenwaelder S.M., Fischer T.H., and White G.C. Rap1b is required for normal platelet function and hemostasis in mice (vol 115, pg 680, 2005). J. Clin. Invest. 115 (2005) 2296-2296
22. Chrzanowska-Wodnicka M., Kraus A.E., Gale D., White II G.C., and VanSluys J. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 111 (2008) 2647-2656
23. Cooke V.G., Naik M.U., and Naik U.P. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscl. Thromb. Vasc. Biol. 26 (2006) 2005-2011
24. Cullere X., Shaw S.K., Andersson L., Hirahashi J., Luscinskas F.W., and Mayadas T.N. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105 (2005) 1950-1955
25. de Rooij J., Zwartkruis F.J.T., Verheijen M.H.G., Cool R.H., Nijman S.M.B., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
26. Defilippi P., Di Stefano P., and Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol. 16 (2006) 257-263
27. Deng C.X., Wynshaw-Boris A., Shen M.M., Daugherty C., Ornitz D.M., and Leder P. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8 (1994) 3045-3057
28. Doebele R.C., Schulze-Hoepfner F.T., Hong J., Chlenski A., Zeitlin B.D., Goel K., Gomes S., Liu Y., Abe M.K., Nor J.E., Lingen M.W., and Rosner M.R. A novel interplay between Epac/Rap1 and MEK5/ERK5 regulates thrombospondin to control angiogenesis. Blood (2009) blood-2009-04-217042
29. Duchniewicz M., Zemojtel T., Kolanczyk M., Grossmann S., Scheele J.S., and Zwartkruis F.J.T. Rap1A-deficient T and B cells show impaired integrin-mediated cell adhesion. Mol. Cell. Biol. 26 (2006) 643-653
30. Ebos J.M.L., Lee C.R., Cruz-Munoz W., Bjarnason G.A., Christensen J.G., and Kerbel R.S. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 15 (2009) 232-239
31. Eliceiri B.P., Klemke R., Stromblad S., and Cheresh D.A. Integrin alpha vbeta 3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140 (1998) 1255-1263
32. Esser S., Lampugnani M., Corada M., Dejana E., and Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111 (1998) 1853-1865
33. Fassler R., and Meyer M. Consequences of lack of [beta]1 integrin gene expression in mice. Genes Dev. 9 (1995) 1896-1908
34. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
35. Ferrara N., Mass R.D., Campa C., and Kim R. Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu. Rev. Med. 58 (2007) 491-504
36. Fujita H., Fukuhara S., Sakurai A., Yamagishi A., Kamioka Y., Nakaoka Y., Masuda M., and Mochizuki N. Local activation of rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule localizes. J. Biol. Chem. 280 (2005) 5022-5031
37. Fukuhara S., Sakurai A., Sano H., Yamagishi A., Somekawa S., Takakura N., Saito Y., Kangawa K., and Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 25 (2005) 136-146
38. Fukuyama T., Ogita H., Kawakatsu T., Fukuhara T., Yamada T., Sato T., Shimizu K., Nakamura T., Matsuda M., and Takai Y. Involvement of the c-Src-Crk-C3G-Rap1 signaling in the nectin-induced activation of Cdc42 and formation of adherens junctions. J. Biol. Chem. 280 (2005) 815-825
39. Fukuyama, T., H. Ogita, T. Kawakatsu, M. Inagaki, and Y. Takai. 2005b. Activation of Rac by cadherin through the c-Src-Rap1-phosphatidylinositol 3-kinase-Vav2 pathway.
40. Garrett T.A., Van Buul J.D., and Burridge K. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. Exp. Cell Res.. 313 (2007) 3285-3297
41. Gavard J., and Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biology. 8 (2006) 1223-U17
42. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., Jeltsch M., Mitchell C., Alitalo K., Shima D., and Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161 (2003) 1163-1177
43. Giancotti F.G., and Ruoslahti E. Integrin signaling. Science 285 (1999) 1028-1033
44. Ginsberg M.H., Partridge A., and Shattil S.J. Integrin regulation. Curr. Opin. Cell Biol. 17 (2005) 509-516
45. Glading A., Han J., Stockton R.A., and Ginsberg M.H. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 179 (2007) 247-254
46. Gore A.V., Lampugnani M.G., Dye L., Dejana E., and Weinstein B.M. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis. Models Mech. 1 (2008) 275-281
47. Gotoh T., Hattori S., Nakamura S., Kitayama H., Noda M., Takai Y., Kaibuchi K., Matsui H., Hatase O., and Takahashi H. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15 (1995) 6746-6753
48. Han J.W., Lim C.J., Watanabe N., Soriani A., Ratnikov B., Calderwood D.A., Puzon-McLaughlin W., Lafuente E.M., Boussiotis V.A., Shattil S.J., and Ginsberg M.H. Reconstructing and deconstructing agonist-induced activation of integrin alpha IIb beta 3. Curr. Biol. 16 (2006) 1796-1806
49. Hatano N., Mori Y., Oh-hora M., Kosugi A., Fujikawa T., Nakai N., Niwa H., Miyazaki J., Hamaoka T., and Ogata M. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8 (2003) 847-856
50. Hattori M., Tsukamoto N., Nur-e-Kamal M.S., Rubinfeld B., Iwai K., Kubota H., Maruta H., and Minato N. Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol. Cell. Biol. 15 (1995) 552-560
51. He Y., Luo Y., Tang S., Rajantie I., Salven P., Heil M., Zhang R., Luo D., Li X., Chi H., Yu J., Carmeliet P., Schaper W., Sinusas A.J., Sessa W.C., Alitalo K., and Min W. Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J. Clin. Invest. 116 (2006) 2344-2355
52. Hodivala-Dilke K.M. [Beta]3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103 (1999) 229-238
53. Hong J., Doebele R.C., Lingen M.W., Quilliam L.A., Tang W.-J., and Rosner M.R. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J. Biol. Chem. 282 (2007) 19781-19787
54. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
55. Hynes R.O. Cell-matrix adhesion in vascular development. J. Thromb. Haemost. 5 (2007) 32-40
56. Katagiri K., Maeda A., Shimonaka M., and Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 4 (2003) 741-748
57. Kiosses W.B., Shattil S.J., Pampori N., and Schwartz M.A. Rac recruits high-affinity integrin alpha v beta 3 to lamellipodia in endothelial cell migration. Nat. Cell Biol. 3 (2001) 316-320
58. Kooistra M.R.H., Dube N., and Bos J.L. Rap1: a key regulator in cell-cell junction formation. J. Cell Sci. 120 (2007) 17-22
59. Korff T., and Augustin H.G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 143 (1998) 1341-1352
60. Laberge-le Couteulx S., Jung H.H., Labauge P., Houtteville J.P., Lescoat C., Cecillon M., Marechal E., Joutel A., Bach J.F., and Tournier-Lasserve E. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 23 (1999) 189-193
61. Lafuente E.M., van Puijenbroek A.A.F.L., Krause M., Carman C.V., Freeman G.J., Berezovskaya A., Constantine E., Springer T.A., Gertler F.B., and Boussiotis V.A. RIAM, an Ena/VASP and profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev. Cell. 7 (2004) 585-595
62. Larsson H., Klint P., Landgren E., and Claesson-Welsh L. Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J. Biol. Chem. 274 (1999) 25726-25734
63. Lee H.-S., Lim C.J., Puzon-McLaughlin W., Shattil S.J., and Ginsberg M.H. RIAM activates integrins by linking talin to Ras GTPase membrane-targeting sequences. J. Biol. Chem. 284 (2009) 5119-5127
64. Li Y., Yan J., De P., Chang H.-C., Yamauchi A., Christopherson II K.W., Paranavitana N.C., Peng X., Kim C., Munugulavadla V., Kapur R., Chen H., Shou W., Stone J.C., Kaplan M.H., Dinauer M.C., Durden D.L., and Quilliam L.A. Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J. Immunol. 179 (2007) 8322-8331
65. Li X.C., Stankovic M., Lee B.P.L., Aurrand-Lions M., Hahn C.N., Lu Y., Imhof B.A., Vadas M.A., and Gamble J.R. JAM-C induces endothelial cell permeability through its association and regulation of beta(3) integrins. Arterioscl. Thromb. Vasc. Biol. 29 (2009) 1200-U101
66. llic D.K., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., Yamamoto T., and AizawaShinichi. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377 (1995) 539-544
67. Loges S., Mazzone M., Hohensinner P., and Carmeliet P. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell. 15 (2009) 167-170
68. Lyle K.S., Raaijmakers J.H., Bruinsma W., Bos J.L., and de Rooij J. cAMP-induced Epac-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics. Cell. Signal. 20 (2008) 1104-1116
69. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., Sonenberg N., Hynes R.O., and Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295 (2002) 140-143
70. Mahabeleshwar G.H., Feng W.Y., Phillips D.R., and Byzova T.V. Integrin signaling is critical for pathological angiogenesis. J. Exp. Med. 203 (2006) 2495-2507
71. Mahabeleshwar G.H., Feng W., Reddy K., Plow E.F., and Byzova T.V. Mechanisms of integrin vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ. Res. 101 (2007) 570-580
72. Mei F.C., and Cheng X.D. Interplay between exchange protein directly activated by cAMP (Epac) and microtubule cytoskeleton. Mol. Biosyst. 1 (2005) 325-331
73. Mirzapoiazova T., Kolosova I., Usatyuk P.V., Natarajan V., and Verin A.D. Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 291 (2006) L718-724
74. Mudgett J.S., Ding J., Guh-Siesel L., Chartrain N.A., Yang L., Gopal S., and Shen M.M. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. PNAS 97 (2000) 10454-10459
75. Nagashima K.I., Endo A., Ogita H., Kawana A., Yamagishi A., Kitabatake A., Matsuda M., and Mochizuki N. Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol. Biol. Cell. 13 (2002) 4231-4242
76. Naik M.U., and Naik U.P. Differential regulation of bFGF- and VEGF-Induced angiogenesis in mice lacking junctional adhesion molecule-A. Blood 106 (2005) 533
77. Naik M.U., and Naik U.P. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha(v)beta(3) specific. J. Cell Sci. 119 (2006) 490-499
78. Naik M.U., Mousa S.A., Parkos C.A., and Naik U.P. Signaling through JAM-1 and alpha(nu)beta(3) is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alpha(nu)beta(3) complex. Blood 102 (2003) 2108-2114
79. Ohba Y., Mochizuki N., Yamashita S., Chan A.M., Schrader J.W., Hattori S., Nagashima K., and Matsuda M. Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. J. Biol. Chem. 275 (2000) 20020-20026
80. Ohba Y., Ikuta K., Ogura A., Matsuda J., Mochizuki N., Nagashima K., Kurokawa K., Mayer B.J., Maki K., Miyazaki J.-i., and Matsuda M. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J. 20 (2001) 3333-3341
81. Orlova V.V., Economopoulou M., Lupu F., Santoso S., and Chavakis T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J. Exp. Med. 203 (2006) 2703-2714
82. Pàez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Viñals F., Inoue M., Bergers G., Hanahan D., and Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 15 (2009) 220-231
83. Pannekoek W.J., Kooistra M.R.H., Zwartkruis F.J.T., and Bos J.L. Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim. Biophys. Acta-Biomembr. 1788 (2009) 790-796
84. Pizon V., Chardin P., Lerosey I., Olofsson B., and Tavitian A. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region. Oncogene 3 (1988) 201-4
85. Pizon V., Lerosey I., Chardin P., and Tavitian A. Nucleotide sequence of a human cDNA encoding a ras-related protein (rap1B). Nucleic Acids Res. 16 (1988) 7719
86. Polakis P.G., Rubinfeld B., Evans T., and McCormick F. Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 239-243
87. Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., and Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytok. Growth Factor Rev. 16 (2005) 159-178
88. Reed M.J., Karres N., Eyman D., and Vernon R.B. Culture of murine aortic explants in 3-dimensional extracellular matrix: a novel, miniaturized assay of angiogenesis in vitro. Microvasc. Res. 73 (2007) 248-252
89. Retta S.F., Balzac F., and Avolio M. Rap1: a turnabout for the crosstalk between cadherins and integrins. Eur. J. Cell Biol. 85 (2006) 283-293
90. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., and Horwitz A.R. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
91. Roberts D.M., Anderson A.L., Hidaka M., Swetenburg R.L., Patterson C., Stanford W.L., and Bautch V.L. A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters. Mol. Cell. Biol. 24 (2004) 10515-10528
92. Robinson J.R., Awad I.A., and Little J.R. Natural history of the cavernous angioma. J. Neurosurg. 75 (1991) 709-714
93. Rousseau S., Houle F., Landry J., and Huota J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15 (1997) 2169-2177
94. Rubinfeld B., Munemitsu S., Clark R., Conroy L., Watt K., Crosier W.J., McCormick F., and Polakis P. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell 65 (1991) 1033-1042
95. Sahoo T., Johnson E.W., Thomas J.W., Kuehl P.M., Jones T.L., Dokken C.G., Touchman J.W., Gallione C.J., Lee-Lin S.Q., Kosofsky B., Kurth J.H., Louis D.N., Mettler G., Morrison L., Gil-Nagel A., Rich S.S., Zabramski J.M., Boguski M.S., Green E.D., and Marchuk D.A. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 8 (1999) 2325-2333
96. Sakamoto Y., Ogita H., Hirota T., Kawakatsu T., Fukuyama T., Yasumi M., Kanzaki N., Ozaki M., and Takai Y. Interaction of Integrin {alpha}vbeta3 with nectin: implication in cross-talk between cell-matrix and cell-cell junctions. J. Biol. Chem. 281 (2006) 19631-19644
97. Sakamoto Y., Ogita H., Komura H., and Takai Y. Involvement of nectin in inactivation of integrin {alpha}v 3 after the establishment of cell-cell adhesion. J. Biol. Chem. 283 (2008) 496-505
98. Sakisaka T., Ikeda W., Ogita H., Fujita N., and Takai Y. The roles of nectins in cell adhesions: cooperation with other cell adhesion molecules and growth factor receptors. Curr. Opin. Cell Biol. 19 (2007) 593-602
99. Sakurai A., Fukuhara S., Yamagishi A., Sako K., Kamioka Y., Masuda M., Nakaoka Y., and Mochizuki N. MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Mol. Biol. Cell. 17 (2006) 966-976
100. Sehrawat S., Cullere X., Patel S., Italiano Jr. J., and Mayadas T.N. Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol. Biol. Cell. 19 (2008) 1261-1270
101. Serebriiskii I., Estojak J., Sonoda G., Testa J.R., and Golemis E.A. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15 (1997) 1043-1049
102. Severson E.A., Lee W.Y., Capaldo C.T., Nusrat A., and Parkos C.A. Junctional adhesion molecule a interacts with afadin and PDZ-GEF2 to activate Rap1A, regulate beta 1 integrin levels, and enhance cell migration. Mol. Biol. Cell. 20 (2009) 1916-1925
103. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.-F., Breitman M.L., and Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
104. Sheta E.A., Harding M.A., Conaway M.R., and Theodorescu D. Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor. J. Natl. Cancer Inst. 92 (2000) 1065-1073
105. Small J.V., Geiger B., Kaverina I., and Bershadsky A. How do microtubules guide migrating cells?. Nat. Rev. Mol. Cell Biol. 3 (2002) 957-964
106. Soga N., Connolly J.O., Chellaiah M., Kawamura J., and Hruska K.A. Rac regulates vascular endothelial growth factor stimulated motility. Cell Commun. Adhes. 8 (2001) 1-13
107. Somanath P.R., Malinin N.L., and Byzova T.V. Cooperation between integrin alpha(V)beta(3) and VEGFR2 in angiogenesis. Angiogenesis 12 (2009) 177-185
108. Stephens L.E. Deletion of [beta]1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. 9 (1995) 1883-1895
109. Stoletov K.V., and Terman B.I. Bmx is a downstream Rap1 effector in VEGF-induced endothelial cell activation. Biochem. Biophys. Res. Commun. 320 (2004) 70-75
110. Stoletov K.V., Gong C.H., and Terman B.I. Nck and Crk mediate distinct VEGF-induced signaling pathways that serve overlapping functions in focal adhesion turnover and integrin activation. Exp. Cell Res. 295 (2004) 258-268
111. Stork P.J. Does Rap1 deserve a bad Rap?. Trends Biochem. Sci. 28 (2003) 267-275
112. Stromblad S., Becker J.C., Yebra M., Brooks P.C., and Cheresh D.A. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J. Clin. Invest. 98 (1996) 426-433
113. Takahashi T., Ueno H., and Shibuya M. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18 (1999) 2221-2230
114. Tamagnone L., Lahtinen I., Mustonen T., Virtaneva K., Francis F., Muscatelli F., Alitalo R., Smith C.I., Larsson C., and Alitalo K. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2 9 12 (1994) 3683-3688
115. Tanjore H., Zeisberg E.M., Gerami-Naini B., and Kalluri R. Beta 1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis. Dev. Dyn. 237 (2008) 75-82
116. Uemura A., Kusuhara S., Katsuta H., and Nishikawa S.-I. Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp. Cell Res. 312 (2006) 676-683
117. Vestweber D. VE-cadherin - the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscl. Thromb. Vasc. Biol. 28 (2008) 223-232
118. Voss A.K., Gruss P., and Thomas T. The guanine nucleotide exchange factor C3G is necessary for the formation of focal adhesions and vascular maturation. Development 130 (2003) 355-367
119. Wallez Y., and Huber P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim. Biophys. Acta-Biomembr. 1778 (2008) 794-809
120. Wang Z., Dillon T.J., Pokala V., Mishra S., Labudda K., Hunter B., and Stork P.J.S. Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol. Cell. Biol. 26 (2006) 2130-2145
121. Wei P., Satoh T., Edamatsu H., Aiba A., Setsu T., Terashima T., Kitazawa S., Nakao K., Yoshikawa Y., Tamada M., and Kataoka T. Defective vascular morphogenesis and mid-gestation in mice lacking RA-GEF-1. Biochem. Biophys. Res. Commun. 363 (2007) 106-112
122. Weis S., Cui J., Barnes L., and Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J. Cell Biol. 167 (2004) 223-229
123. Weis S.M., Lindquist J.N., Barnes L.A., Lutu-Fuga K.M., Cui J., Wood M.R., and Cheresh D.A. Cooperation between VEGF and {beta}3 integrin during cardiac vascular development. Blood 109 (2007) 1962-1970
124. Whitehead K.J., Plummer N.W., Adams J.A., Marchuk D.A., and Li D.Y. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131 (2004) 1437-1448
125. Wittchen E.S., Worthylake R.A., Kelly P., Casey P.J., Quilliam L.A., and Burridge K. Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J. Biol. Chem. 280 (2005) 11675-11682
126. Yan J.L., Li F., Ingram D.A., and Quilliam L.A. Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Mol. Cell. Biol. 28 (2008) 5803-5810
127. Yang J.T., Rayburn H., and Hynes R.O. Embryonic mesodermal defects in [alpha]5 integrin-deficient mice. Development 119 (1993) 1093-1105
128. Zachary I., and Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49 (2001) 568-581
129. Zawistowski J.S., Serebriiskii I.G., Lee M.F., Golemis E.A., and Marchuk D.A. KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Human Mol. Genet. 11 (2002) 389-396
130. Zhang J., Clatterbuck R.E., Rigamonti D., Chang D.D., and Dietz H.C. Interaction between krit1 and icap1 alpha infers perturbation of integrin beta 1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Human Mol. Genet. 10 (2001) 2953-2960
131. Zhang J., Basu S., Rigamonti D., Dietz H.C., and Clatterbuck R.E. Krit1 modulates beta 1-integrin-mediated endothelial cell proliferation. Neurosurgery 63 (2008) 571-578
132. Zhu W.-H., and Nicosia R. The thin prep rat aortic ring assay: a modified method for the characterization of angiogenesis in whole mounts. Angiogenesis 5 (2002) 81-86